Private Equity

Updated:

Quadria Capital

Quadria Capital is Asia’s premier healthcare investor and one of Asia’s largest healthcare-focused private equity firms. It manages over US$4 billion in assets...

Quadria Capital logo

Quadria Capital

Quadria Capital is Asia’s premier healthcare investor and one of Asia’s largest healthcare-focused private equity firms. It manages over US$4 billion in assets across investments in South and Southeast Asia including India, Vietnam, Indonesia, Malaysia, Singapore and Dubai. The firm partners with exceptional healthcare businesses to enhance their impact and scale while generating superior returns for investors.

General information

Firm type

Private Equity

Year founded

2012

AUM

$4B+

Location

Region

Asia

Country

Singapore

City

Singapore

Corporate office

158 Cecil Street, #03-01, Singapore 069545

Additional offices

New Delhi, India · Ho Chi Minh City, Vietnam · Jakarta, Indonesia

Principals

Abrar Mir

Co-founder and Managing Partner

Dr Amit Varma

Co-Founder and Managing Partner

Sunil Thakur

Partner and Head of South Asia

Ewan Davis

Partner

Gerald Ng

Head of Investor Relations

Sector focus

Healthcare DeliveryLife SciencesMedTechDigital HealthPharmaceuticalsMedical DevicesDiagnostics

Frequently asked questions

What is Quadria Capital's investment strategy?

Quadria targets growth-stage and late-stage healthcare companies in Asia with strong market differentiation and scalable models. The firm takes an industrial approach to value creation, leveraging an in-house operational excellence team. Investments span healthcare delivery, life sciences, medical devices, diagnostics, and digital health.

Which geographies does Quadria Capital cover?

Quadria invests primarily in India and Southeast Asia. The firm maintains offices in Singapore, New Delhi, Ho Chi Minh City, and Jakarta. Portfolio companies serve markets across India, Malaysia, the Philippines, Uzbekistan, and Nepal.

What is Quadria Capital's sector focus within healthcare?

Quadria invests across the healthcare ecosystem: hospitals, dialysis networks, eye care chains, pharmaceutical contract research and manufacturing (CRDMO), orthopedic device CDMOs, digital health platforms, topical drugs, and personal hygiene. The firm explicitly targets companies that can become regional market leaders.

Who runs investment decisions at Quadria Capital?

Quadria has not publicly disclosed its investment committee composition or named its managing partners on the current website. The firm describes one of the largest dedicated healthcare investment teams in Asia, but individual decision-makers are not identified in primary sources.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Singapore Private Equity profiles